Huan Zhu
China to Implement Extraterritorial Rare Earth Export Controls
Last week, the Chinese Ministry of Commerce (MOFCOM) issued new rules imposing extraterritorial export control measures for rare earth items. The new regime effectively extends China's regulatory reach beyond its borders, further completing a system that mirrors the legal framework of U.S. export controls.
China Adds 23 Firms to Unreliable Entity List
Today, China's Ministry of Commerce sanctioned 14 Western companies and several affiliates in the defense and intelligence sectors by adding them to the unreliable entity list.
China Expands Rare Earth Export Controls
Today, China's Ministry of Commerce expanded its dual-use item list for export control purposes, by adding rare earths, rare earth-related technologies, raw materials, alloys, and processing equipment to the list, further tightening its export controls over the rare earth supply chain.
New export controls
According to MOFCOM'
China and U.S. Exchange Criticism at the WTO
Yesterday, China's top envoy to the World Trade Organization (WTO) accused the United States of disrupting global supply chains and using "power-based" trade policies that are eroding the rules-based multilateral system. The U.S. delegation pushed back and accused China of "incentiviz[ing] massive economic
Taiwan's Two-Day Sanction on South Africa: Cautious Chip Diplomacy
Taiwan issued its first-ever nationwide export controls in late September, which were then swiftly reversed. Nonetheless, the move is still significant, as it signals an effort by Taipei to leverage its dominance in the semiconductor industry for political aims.
China Warns Mexico as Trade Remedy Cases Rise
Trade friction is escalating between China and Mexico. Following the opening of a new investigation into the Mexican government's trade practices, China's Ministry of Commerce has now issued a rebuke against rising trade remedy investigations into Chinese goods, characterizing this trend as a sign that Mexico
China Establishes Biopharma Pilot Project in Jiangsu
In a strategic move designed to bolster its bioeconomy, China’s State Council recently approved a new pilot program in the Jiangsu Free Trade Zone (FTZ), which will be used as a testing ground for system-wide innovation in the biopharma sector. One of the core innovations of the plan is